Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10850345)

  • 1. Disease stage prognostic indices in the early clinical screening of colorectal cancer patients.
    Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Casciani CU; Adorno D
    Cancer Biother Radiopharm; 1998 Apr; 13(2):89-98. PubMed ID: 10850345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of immunological evaluation in colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Maccarone D; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):355-61. PubMed ID: 10851496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer.
    Berghella AM; Contasta I; Pellegrini P; Del Beato T; Adorno D
    Cancer Biother Radiopharm; 2002 Feb; 17(1):43-50. PubMed ID: 11915173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 and sIL-2R serum levels as possible peripheral blood prognostic markers in the passage from adenoma to colorectal cancer.
    Berghella AM; Pellegrini P; Del Beato T; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):265-72. PubMed ID: 10851474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer.
    Contasta I; Pellegrini P; Berghella AM; Del Beato T; Canossi A; Di Rocco M; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1996 Dec; 11(6):373-83. PubMed ID: 10851498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the soluble CD30 serum level in colorectal cancer: a possible marker for a patient subset which could benefit from IL-2 biotherapy.
    Dle Beato T; Berghella AM; Pellegrini P; Domenico A; Casciani CU
    Cancer Biother Radiopharm; 1997 Oct; 12(5):297-304. PubMed ID: 10851480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma.
    Clinchy B; Fransson A; Druvefors B; Hellsten A; Håkansson A; Gustafsson B; Sjödahl R; Håkansson L
    Cancer; 2007 May; 109(9):1742-9. PubMed ID: 17345614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
    Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
    Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of Edrecolomab (Mo17-1A) or fluorouracil-based chemotherapy on specific immune parameters in patients with colorectal cancer. A comparative study.
    Tsavaris NB; Katsoulas HL; Kosmas C; Papalambros E; Gouveris P; Papantoniou N; Rokana S; Kosmas N; Skopeliti M; Tsitsilonis OE
    Oncology; 2004; 67(5-6):403-10. PubMed ID: 15713997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer.
    Pellegrini P; Berghella AM; Del Beato T; Maccarone D; Cencioni S; Adorno D; Casciani CU
    Cancer Biother Radiopharm; 1997 Aug; 12(4):257-64. PubMed ID: 10851473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Nutritional Index Predicts Severe Complications, Recurrence, and Poor Prognosis in Patients With Colorectal Cancer Undergoing Primary Tumor Resection.
    Tokunaga R; Sakamoto Y; Nakagawa S; Miyamoto Y; Yoshida N; Oki E; Watanabe M; Baba H
    Dis Colon Rectum; 2015 Nov; 58(11):1048-57. PubMed ID: 26445177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic determinants of survival after resection of T3N0 (Stage IIA) colorectal cancer: proposal for a new prognostic model.
    Cianchi F; Messerini L; Comin CE; Boddi V; Perna F; Perigli G; Cortesini C
    Dis Colon Rectum; 2007 Sep; 50(9):1332-41. PubMed ID: 17429709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
    Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
    Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma.
    Werther K; Christensen IJ; Nielsen HJ;
    Br J Cancer; 2002 Feb; 86(3):417-23. PubMed ID: 11875709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An elevated preoperative serum carbohydrate antigen 19-9 level is a significant predictor for peritoneal dissemination and poor survival in colorectal cancer.
    Takakura Y; Ikeda S; Imaoka Y; Urushihara T; Itamoto T
    Colorectal Dis; 2015 May; 17(5):417-25. PubMed ID: 25512077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel data-driven prognostic model for staging of colorectal cancer.
    Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
    J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer, and correlations with clinicopathological features and prognosis. M-CSF - an independent prognostic factor.
    Kaminska J; Kowalska M; Kotowicz B; Fuksiewicz M; Glogowski M; Wojcik E; Chechlinska M; Steffen J
    Oncology; 2006; 70(2):115-25. PubMed ID: 16645324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.
    Masson D; Denis MG; Denis M; Blanchard D; Loirat MJ; Cassagnau E; Lustenberger P
    Br J Cancer; 1999 Aug; 80(12):1995-2000. PubMed ID: 10471052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.